< Back to Press Releases

HCL Partners With Visiprise to Provide Professional Services to Global Manufacturers in the Medical Device Industry

ATLANTA – January 22, 2008 - HCL Technologies Ltd. ('HCL'), leading global IT services company, has entered into a global consulting partnership with Visiprise, Inc. for the Life Sciences industry, covering all aspects of the medical device manufacturing cycle. Visiprise provides manufacturing execution solutions (MES) that help global manufacturers to gain visibility into operations, achieve shop floor control and manage product and process traceability. The consulting agreement will include joint marketing, sales and pre-sales services and will result in the ability for seamless licensing, blueprinting, implementation, plant-business integration, roll-out, support, upgrade / migration and instance consolidation services to manufacturers.

The strategic partnership will further strengthen HCL's position as 'innovators/leaders' in the Manufacturing IT landscape with initial focus on medical devices further expanding to Hitech, Aerospace, Auto and other discrete industries. Under this agreement Visiprise will also be training and certifying HCL consultants on Visiprise solutions.

Speaking on the occasion Mr. Pradep Nair, VP, Global Life Sciences and Healthcare practice, HCL Technologies, said, 'With increasing global competition, it is imperative for manufacturers to innovate faster, cheaper, with sustained/better quality meeting stringent regulatory norms. Manufacturers are therefore making strategic investments in comprehensive IT solutions focused towards improving efficiency in the plant operations and increasing collaboration between engineering, enterprise and plant functions as well as extended eco systems such as partners and suppliers. HCL's partnership with Visiprise is well poised in bringing about the transformational change in plant operations. We believe that Visiprise's technology and strategic alignment with SAP and PLM vendors will help customers in seamless business integration from shop-floor to top-floor, which aligns well with HCL's focus towards Manufacturing IT solutions and services.'

'HCL's focus in medical devices, coupled with their comprehensive approach in providing total plant-level IT aligns well with our vision of delivering a total manufacturing solution for the integrated enterprise,' said Mike Lackey, Vice President of industry business units from Visiprise. 'HCL Technologies has a global footprint and a proven ability to deliver solutions in a complex, manufacturing environment.'

Commenting on the partnership, Ralph Rio, Director ARC Advisory, remarks, 'Among the discrete industries, the competitive landscape today demands a speed of execution that is driving the adoption of MES applications like Visiprise. In addition, electronic records provided by MES applications are needed for compliance with US FDA regulations. Our research shows rapid MES market growth that recently reached 27% year-to-year. The HCL and Visiprise partnership helps fill this major market opportunity with software and support for the lifecycle of a MES project.' The ARC Advisory Group is a leading research, advisory firm and the thought leaders in manufacturing, logistics and supply chain solutions.

About Visiprise, Inc.

Visiprise is a leading provider of manufacturing execution for integrated manufacturing operations. Visiprise helps manufacturers gain visibility into manufacturing operations, achieve shop floor control and manage product and process traceability. Focused on aerospace and defense, high tech, automotive, and medical device industries, more than 200 customers around the globe turn to Visiprise. Customers include Actia, BAE Systems, Celestica, ConMed, E-Z-GO Textron, Lockheed Martin, Philips Lighting, Solectron and Thales Avionics. For more information, visit www.visiprise.com.

About HCL's Life Sciences & Healthcare Practice

The Life Sciences & Healthcare practice at HCL delivers IT centric solutions across the pharmaceutical, medical device and hospital industries. The DNA of the practice lies in extension of this knowledge to provide focused IT services and solutions to the customers. HCL's investments have strong focus on regulatory compliance prescribed by the FDA's CFR, CEC, ISO, HIPAA and meeting technology paradigms surrounding HL7, DICOM, and others. HCL continues to invest in providing tested solutions in arenas such as Pharmacogenomics, medical devices and diagnostics, contract manufacturing, and hospital information systems. The Life Sciences & Healthcare team comprises 1500 consultants, including regulatory experts, bio technologists and pharmaceutical industry experts.

About HCL Technologies

HCL Technologies is one of India's leading global IT Services companies, providing software-led IT solutions, remote infrastructure management services and BPO. Having made a foray into the global IT landscape in 1999 after its IPO, HCL Technologies focuses on Transformational Outsourcing, working with clients in areas that impact and re-define the core of their business. The company leverages an extensive global offshore infrastructure and its global network of offices in 18 countries to deliver solutions across select verticals including Financial Services, Retail & Consumer, Life Sciences & Healthcare, Hi-Tech & Manufacturing, Telecom and Media & Entertainment (M&E). For the quarter ended 30th September 2007, HCL Technologies, along with its subsidiaries had last twelve months (LTM) revenue of US $ 1.6 billion (Rs. 6715 crores) and employed 47,954 professionals. For more information, please visit www.hcltech.com

About HCL Enterprise

HCL Enterprise is a $4.5 billion (Rs. 18,877 crore) leading Global Technology and IT enterprise that comprises two companies listed in India - HCL Technologies & HCL Infosystems. The 3-decade-old enterprise, founded in 1976, is one of India's original IT garage start-ups. Its range of offerings span Product Engineering, Custom & Package Applications, BPO, IT Infrastructure Services, IT Hardware, Systems Integration, and distribution of ICT products. The HCL team comprises approximately 53,000 professionals of diverse nationalities, who operate from 18 countries including 360 points of presence in India. HCL has global partnerships with several leading Fortune 1000 firms, including leading IT and Technology firms. For more information, please visit www.hcl.in

Forward-looking Statements
Certain statements in this release are forward-looking statements, which involve a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ materially from those in such forward-looking statements. All statements, other than statements of historical fact are statements that could be deemed forward-looking statements, including but not limited to the statements containing the words 'planned,' 'expects,' 'believes,' 'strategy,' 'opportunity,' 'anticipates,' 'hopes' or other similar words. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding impact of pending regulatory proceedings, fluctuations in earnings, our ability to manage growth, intense competition in IT services, Business Process Outsourcing and consulting services including those factors which may affect our cost advantage, wage increases in India, customer acceptances of our services, products and fee structures, our ability to attract and retain highly skilled professionals, our ability to integrate acquired assets in a cost effective and timely manner, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, our ability to successfully complete and integrate potential acquisitions, the success of our brand development efforts, liability for damages on our service contracts, the success of the companies /entities in which we have made strategic investments, withdrawal of governmental fiscal incentives, political instability, legal restrictions on raising capital or acquiring companies outside India, and unauthorized use of our intellectual property, other risks, uncertainties and general economic conditions affecting our industry. There can be no assurance that the forward-looking statements made herein will prove to be accurate, and issuance of such forward-looking statements should not be regarded as a representation by the Company, or any other person, that the objective and plans of the Company will be achieved. All forward-looking statements made herein are based on information presently available to the management of the Company and the Company does not undertake to update any forward-looking statement that may be made from time to time by or on behalf of the Company.